Session V: Therapeutic Strategies for Addressing Deafness and Vestibular Defects: From Rehabilitation to Gene Therapy
Chairs: Prof. Anne-SCHILDER, Dr. Hinrich STAECKER, Prof Fouad BENARIBA
* All times are based on Europe/Paris CEST.
Europe/Paris
Europe/Paris
Europe/Paris
Hearing Loss Innovation: Expanding Frontiers in Protection & Restoration Moderator: Nawal OUZREN, Chief Executive Officer, Sensorion - Protecting Hair cells, Preserving Hearing: The Potential of SENS-401 Prof. Yann NGUYEN, Department of Otolaryngology-Head & Neck Surgery, Pitié-Salpêtrière Hospital, Paris. - From Bench to Bedside: The Journey of GJB2 & OTOF Gene Therapies for Children with Severe to Profound Hearing Loss. · Advancing Gene Therapy for OTOF-Related Hearing Loss in Young Children. Prof. Natalie LOUNDON, Pediatric Department of Otolaryngology-Head & Neck Surgery, Necker Enfants Malades, Paris. · Developing Novel Gene Therapy for Hereditary Hearing Loss in Patients with GJB2 Mutations. Dr. Laurent DESIRE, PhD, Head of Preclinical Development, Sensorion. - Q&A Session & Conclusion: Nawal OUZREN, Chief Executive Officer, Sensorion
Europe/Paris
Europe/Paris
Europe/Paris